For the 2024 Testicular Cancer Guidelines, the key changes incorporated in this publication include:
- A restructure and update of section 5.2 on Imaging of primary tumours and staging;
- An update on the summary of evidence table 6.1.2.5;
- Restructure and rewrite of section 6.2.2 on Metastatic disease (stage IIA/B);
- New recommendation regarding the treatment of metastatic NSGCT with a poor prognosis section 6.3.6.1;
- New section 8.5 on follow-up of rare and adult para- and testicular cancers.